Instrumento Inactivo

Otros idiomas GX Acquisition Corp.

Acciones

GXGX

US36251A1079

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

GX Acquisition : Clinical pipeline includes multiple clinical stage programs including acute myeloid leukemia (AML) and glioblastoma multiforme (GBM), with a total of five clinical programs expected by 1H 2022 (Form 8-K)	22/07/21
Celularity Closes Merger With GX Acquisition Corp	16/07/21
Celularity Inc. completed the acquisition of GX Acquisition Corp. in a reverse merger transaction.	16/07/21
GX Acquisition : Submission of Matters to a Vote of Security Holders (Form 8-K)	15/07/21
GX Acquisition Corp. Approves Elections of Nine Directors	15/07/21
GX ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders (form 8-K)	15/07/21
GX Acquisition Corp.(NasdaqCM:GXGX) dropped from NASDAQ Composite Index	15/07/21
GX Acquisition : Arthrex to receive exclusive rights to distribute and commercialize Celularity’s placental-derived biomaterial products for orthopedics and sport medicine in the United States (Form 8-K)	02/07/21
GX ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	01/07/21
GX Acquisition : Celularity Announces Expansion of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK-001) Phase 1 Trial in Patients with Acute Myeloid Leukemia (Form 8-K)	29/06/21
GX ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	29/06/21
GX ACQUISITION : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	24/05/21
Gx Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	24/05/21
GX ACQUISITION : 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	24/05/21
GX ACQUISITION CORP. : Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	14/05/21
GX Acquisition Corp. : Announces Shareholder Approval of Extension Proposal	14/05/21
GX Acquisition : Announces Additional Contributions to Trust Account (Form 8-K)	12/05/21
GX ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)	10/05/21
GX Acquisition Corp. : Announces Additional Contributions to Trust Account	10/05/21
GX Acquisition : Celularity to leverage Palantir’s next generation software and computational capabilities with their deep cellular data set to accelerate research and development activities	06/05/21

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas GX Acquisition Corp.

Acciones

GXGX

US36251A1079

Otros idiomas

Filtros